Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMBER-NAC: Neoadjuvant Chemotherapy vs Upfront Cystectomy in Luminal Bladder Cancer
NCT07762586Phase 2Recruiting
- Sponsor
- Rutgers University
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in bladder cancer (2 arms), sponsored by Rutgers University. Primary endpoint: Pathological upstaging rate at radical cystectomy (pT3-pT4 or pN+). Started Jul 2026; status: recruiting.
02
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT07762586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762586.